Pune, India, May 25, 2022 (GLOBE NEWSWIRE) -- The global Polymerase Chain Reaction Market size was USD 7.10 billion in 2020. The market is projected to grow from USD 7.80 billion in 2021 to USD 13.75 billion in 2028 at a CAGR of 8.4% in the 2021-2028 period.
According to our researchers, the growth in occurrence of infectious diseases, cancer, and genetic diseases and the increase in the utilization for diagnosing such conditions is the crucial factor accountable for enhancing the market growth during the forecast period.
Key Industry Development
July 2021 - PathStore declared the unveiling of COVID-19 RT-PCR test in India at the lowest price in comparison with other companies. This rapid test is pointed towards getting the most out of COVID-19 diagnosis to assure well-timed treatment.
Request a Sample Copy of the Research Report:
Report Scope & Segmentation:
| Report Coverage | Details |
| Forecast Period | 2021-2028 |
| Forecast Period 2021 to 2028 CAGR | 8.4% |
| 2028 Value Projection | USD 13.75 billion |
| Base Year | 2020 |
| Market Size in 2020 | USD 7.10 billion |
| Historical Data for | 2017-2019 |
| No. of Pages | 135 |
| Segments covered | By Type, By Product, By Indication, By End User, By Geography |
| Growth Drivers | The growing prevalence of these infectious diseases is leading to the higher demand for the products for diagnosis, and thus poised to accelerate the market growth. |
| High cost of assays conducted in emerging nations is likely to decrease the adoption of the devices resulting in limiting the market growth. |
Market Growth Drivers
Improvements in PCR Procedures to Hasten Market Growth
Polymerase Chain Reaction is an enzyme-powered procedure intended for augmenting a small area of DNA in-vitro. In spite of this power of magnification, restrictions in its sustaining hardware obstruct from reaching its full prospective. Technological progressions and surging demand for ground-breaking devices have resulted in the introduction of contraction of the devices in the market. These shrunken devices provide abundant medical profits to patients as well as healthcare suppliers which will drive the polymerase chain reaction market growth.
Report Coverage
The Polymerase Chain Reaction Market share report delivers valued understandings attained by detailed study done by our researchers. An all-encompassing research was conducted to provide the projected size of the market. The data executed to accentuate the shares for manifold segments at the national, domestic, and global stages is attained from in-depth interviews with several stakeholders. Additionally, our researchers have gained admittance to numerous international as well as regional paid databases to deliver precise information to make business investment choices easy for all the clients.
Click here to get the short-term and long-term impact of COVID-19 on this Market:
https://www.fortunebusinessinsights.com/polymerase-chain-reaction-pcr-market-102528
Segments
- On the basis of type, the Polymerase Chain Reaction Market is segregated into standard PCR, real-time PCR, and digital PCR. The real-time PCR segment dominated the global market share in 2020. Augmentation in demand owing to the COVID-19 pandemic promoted the growth in sales of the companies.
- Based on product, the market is classified into instruments and reagents & consumables.
- By indication, the market is separated into infectious diseases, oncology, genetic disorders, and others.
- On the basis of end-user, the market is categorized into hospitals & clinics, pharmaceutical & biotechnology industries, diagnostic centers, and academic & research organizations.
- In terms of region, the Polymerase Chain Reaction Market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Regional Insights
North America to Dominate Market Share due to Favorable Compensation Guidelines for PCR Devices.
North America held the largest polymerase chain reaction market share and was valued at USD 2.94 billion in 2020. The market in the region is characterized by bigger occurrence and diagnosis rates for contagious illnesses, combined with tolerable compensation guidelines for PCR devices.
Europe is the second largest region owing to the growing occurrence of several kinds of cancer as well as metabolic ailments necessitating unconventional diagnosis and therapies.
The Polymerase Chain Reaction Market in Asia Pacific is anticipated to document a relatively greater CAGR during the forecast period.
Competitive Landscape
Acquisitions Initiated by Fundamental Companies to Promote Market Growth
The leading companies in the Polymerase Chain Reaction Market persistently root for efficient strategies to augment their brand value as well as promote the global market growth of the product with experiencing least conceivable obstacles. One such operative approach is acquiring competitive companies and further guaranteeing an exciting profit for both the involved companies.
Quick Buy - Polymerase Chain Reaction Market:
https://www.fortunebusinessinsights.com/checkout-page/102528
The Report Lists the Key Companies in the Global Polymerase Chain Reaction Market
- Bio-Rad Laboratories, Inc. (California, U.S.)
- QIAGEN (Hilden, Germany)
- F. Hoffmann-La Roche Ltd (Basel, Switzerland)
- Agilent Technologies, Inc. (California, U.S.)
- Abbott (Illinois, U.S.)
- Eppendorf AG (Hamburg, Germany)
- Sysmex Inostics (Hyogo, Japan)
- Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
- BD (New Jersey, U.S.)
Table of Contents
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Polymerase Chain Reaction Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
-
- Prevalence of Chronic Disorders (Infectious diseases, Cancer)
- Key Industry Developments – Mergers, Acquisitions, Partnerships & New Product Launch
- Technological Advancements in PCR
- Regulatory Scenario by Key Countries/Region
-
- Global Polymerase Chain Reaction Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
-
-
- Standard PCR
- Real-time PCR
- Digital PCR
-
-
- Market Analysis, Insights and Forecast – By Product
-
-
- Instruments
- Reagents & Consumables
-
- Market Analysis, Insights and Forecast – By Indication
-
- Infectious Diseases
- Oncology
- Genetic Disorders
- Others
-
-
- Market Analysis, Insights and Forecast – By End User
-
-
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Industries
- Diagnostic Centers
- Academic & Research Organization
-
-
- Market Analysis, Insights and Forecast – By Region
-
-
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
-
-
- North America Polymerase Chain Reaction (PCR) Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
-
-
- Standard PCR
- Real-time PCR
- Digital PCR
-
-
- Market Analysis, Insights and Forecast – By Product
-
-
- Instruments
- Reagents & Consumables
-
-
- Market Analysis, Insights and Forecast – By Indication
-
-
- Infectious Diseases
- Oncology
- Genetic Disorders
- Others
-
-
- Market Analysis, Insights and Forecast – By End User
-
-
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Industries
- Diagnostic Centers
- Academic & Research Organization
-
-
- Market Analysis, Insights and Forecast – By Country
-
-
- U.S.
- Canada
-
-
ToC Continued…
Have Any Query? Ask Our Experts:
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
